The DOI matches its Crossref record; 90 of the 90 references it cites were found in a registry or an index.
Hodgkin lymphoma
Open accessAbstract
Hodgkin lymphoma (HL), a B cell-derived cancer, is one of the most common lymphomas. In HL, the tumor cells--Hodgkin and Reed-Sternberg (HRS) cells--are usually very rare in the tissue. Although HRS cells are derived from mature B cells, they have largely lost their B cell phenotype and show a very unusual co-expression of markers of various hematopoietic cell types. HRS cells show deregulated activation of multiple signaling pathways and transcription factors. The activation of these pathways and factors is partly mediated through interactions of HRS cells with various other types of cells in the microenvironment, but also through genetic lesions. The transforming events involved in the pathogenesis of HL are only partly understood, but mutations affecting the NF-κB and JAK/STAT pathways are frequent. The dependency of HRS cells on microenvironmental interactions and deregulated signaling pathways may offer novel strategies for targeted therapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues
Swerdlow, S. H. (2017) · Medical Entomology and Zoology · Cited by 12,933
Younes, A., Gopal, A. K., Smith, S. E., Ansell, S. M., Rosenblatt, J. D., Savage, K. J., Ramchandren, R., Bartlett, N. L., Cheson, B. D., de Vos, S., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.38.0410 · Cited by 1,529
Self-citationBrentuximab Vedotin (SGN-35) for Relapsed CD30-Positive Lymphomas
Younes, A., Bartlett, N. L., Leonard, J. P., Kennedy, D. A., Lynch, C. M., Sievers, E. L., & Forero-Torres, A. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1002965 · Cited by 1,368
Green, M. R., Monti, S., Rodig, S. J., Juszczynski, P., Currie, T., O'Donnell, E., Chapuy, B., Takeyama, K., Neuberg, D., Golub, T. R., et al. (2010) · Blood · doi:10.1182/blood-2010-05-282780 · Cited by 1,305
Pre-B cell proliferation and lymphoblastic leukemia/high-grade lymphoma in Eμ-miR155 transgenic mice
Costinean, S., Zanesi, N., Pekarsky, Y., Tili, E., Volinia, S., Heerema, N., & Croce, C. M. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0602266103 · Cited by 951
Reduced Treatment Intensity in Patients with Early-Stage Hodgkin's Lymphoma
Engert, A., Plütschow, A., Eich, H. T., Lohri, A., Dörken, B., Borchmann, P., Berger, B., Greil, R., Willborn, K. C., Wilhelm, M., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1000067 · Cited by 928
Self-citationGallamini, A., Hutchings, M., Rigacci, L., Specht, L., Merli, F., Hansen, M., Patti, C., Loft, A., Di Raimondo, F., D'Amore, F., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.11.6525 · Cited by 846
Bargou, R. C., Emmerich, F., Krappmann, D., Bommert, K., Mapara, M. Y., Arnold, W., Royer, H. D., Grinstein, E., Greiner, A., Scheidereit, C., et al. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119849 · Cited by 761
Kanzler, H., Küppers, R., Hansmann, M. L., & Rajewsky, K. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.4.1495 · Cited by 742
Self-citationMultilineage gene expression precedes commitment in the hemopoietic system.
Hu, M., Krause, D., Greaves, M., Sharkis, S., Dexter, M., Heyworth, C., & Enver, T. (1997) · Genes & Development · doi:10.1101/gad.11.6.774 · Cited by 729
Research works printed but not linked: 33
- 10.1056/NEJM199803123381113 · doi:10.1056/nejm199803123381113
- Bräuninger, 2003, Cancer Res., 63, 1644
- Seitz, 2000, Blood., 95, 3020, 10.1182/blood.V95.10.3020 · doi:10.1182/blood.v95.10.3020
- 10.1002/stem.5530060606 · doi:10.1002/stem.5530060606
- 10.1182/blood.V97.3.818 · doi:10.1182/blood.v97.3.818
- 10.1182/blood-2009-06-229583 · doi:10.1182/blood-2009-06-229583
- 10.1111/j.1349-7006.2010.01693.x · doi:10.1111/j.1349-7006.2010.01693.x
- 10.1182/blood-2002-03-0839 · doi:10.1182/blood-2002-03-0839
- 10.1046/j.1365-2559.2000.00830.x · doi:10.1046/j.1365-2559.2000.00830.x
- Küppers, 2003, J Clin Invest., 111, 529, 10.1172/JCI200316624 · doi:10.1172/jci200316624
- Anagnostopoulos, 1989, Blood., 74, 810, 10.1182/blood.V74.2.810.810 · doi:10.1182/blood.v74.2.810.810
- 10.1146/annurev.immunol.16.1.471 · doi:10.1146/annurev.immunol.16.1.471
- 10.1182/blood-2005-06-2342 · doi:10.1182/blood-2005-06-2342
- Weber-Matthiesen, 1995, Blood., 86, 1464, 10.1182/blood.V86.4.1464.bloodjournal8641464 · doi:10.1182/blood.v86.4.1464.bloodjournal8641464
- 10.1158/0008-5472.CAN-06-1992 · doi:10.1158/0008-5472.can-06-1992
- 10.1016/j.cancergencyto.2008.06.007 · doi:10.1016/j.cancergencyto.2008.06.007
- 10.1182/blood.V99.4.1474 · doi:10.1182/blood.v99.4.1474
- Joos, 2000, Cancer Res., 60, 549
- Kapp, 1993, Blood., 82, 1247, 10.1182/blood.V82.4.1247.1247 · doi:10.1182/blood.v82.4.1247.1247
- Vockerodt, 1998, Blood., 92, 2899, 10.1182/blood.V92.8.2899 · doi:10.1182/blood.v92.8.2899
- Carbone, 1995, Am J Pathol., 147, 912
- 10.1111/j.1440-1827.1998.tb03821.x · doi:10.1111/j.1440-1827.1998.tb03821.x
- 10.1136/jcp.48.2.160 · doi:10.1136/jcp.48.2.160
- Engert A Horning SJ Hodgkin Lymphoma. Heidelberg, Germany: Springer; 2011. · doi:10.1007/978-3-642-12780-9
- 10.1007/s00066-008-1882-7 · doi:10.1007/s00066-008-1882-7
- 10.1200/JCO.2006.07.0482 · doi:10.1200/jco.2006.07.0482
- Raemaekers, 2002, Eur J Cancer., 38, S107, 10.1016/S0959-8049(01)00446-4 · doi:10.1016/s0959-8049(01)00446-4
- 10.1093/annonc/mdi323 · doi:10.1093/annonc/mdi323
- 10.1182/blood-2002-08-2644 · doi:10.1182/blood-2002-08-2644
- 10.1182/blood-2007-03-078725 · doi:10.1182/blood-2007-03-078725
- 10.1093/annonc/mdl302 · doi:10.1093/annonc/mdl302
- Younes, 2011, J Clin Oncol., 29
- 10.1111/j.1365-2141.2009.07963.x · doi:10.1111/j.1365-2141.2009.07963.x
Cited by
Cellular Senescence: Defining a Path Forward
Gorgoulis, V., Adams, P. D., Alimonti, A., Bennett, D. C., Bischof, O., Bishop, C., Campisi, J., Collado, M., Evangelou, K., Ferbeyre, G., et al. (2019) · Cell · doi:10.1016/j.cell.2019.10.005 · Cited by 3,225
The ErbB/HER family of protein-tyrosine kinases and cancer
Roskoski, R. (2014) · Pharmacological Research · doi:10.1016/j.phrs.2013.11.002 · Cited by 1,353
Role of PI3K/AKT pathway in cancer: the framework of malignant behavior
Jiang, N., Dai, Q., Su, X., Fu, J., Feng, X., & Peng, J. (2020) · Molecular Biology Reports · doi:10.1007/s11033-020-05435-1 · Cited by 571
Bollard, C. M., Gottschalk, S., Torrano, V., Diouf, O., Ku, S., Hazrat, Y., Carrum, G., Ramos, C., Fayad, L., Shpall, E. J., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.51.5304 · Cited by 503
Anti-CD30 CAR-T Cell Therapy in Relapsed and Refractory Hodgkin Lymphoma
Ramos, C. A., Grover, N. S., Beaven, A. W., Lulla, P. D., Wu, M.-F., Ivanova, A., Wang, T., Shea, T. C., Rooney, C. M., Dittus, C., et al. (2020) · Journal of Clinical Oncology · doi:10.1200/jco.20.01342 · Cited by 386
Metadata
- Authors
- Küppers, R., Engert, A., & Hansmann, M.-L.
- Venue
- Journal of Clinical Investigation
- Published
- 2012-10-01
- Volume
- 122
- Issue
- 10
- Pages
- 3439-3447
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W4252401126
- Cited by
- 286
- References
- 90
- FWCI
- 13.30
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Hodgkin lymphoma. https://app.cochat.ai/papers/10.1172/jci61245
- The paper
- Küppers, R., Engert, A., & Hansmann, M.-L. (2012). Hodgkin lymphoma. Journal of Clinical Investigation. https://doi.org/10.1172/jci61245
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.